2011
DOI: 10.1016/j.gie.2010.12.013
|View full text |Cite
|
Sign up to set email alerts
|

Antiperistaltic effect and safety of l-menthol sprayed on the gastric mucosa for upper GI endoscopy: a phase III, multicenter, randomized, double-blind, placebo-controlled study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

13
58
1
4

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 38 publications
(76 citation statements)
references
References 26 publications
13
58
1
4
Order By: Relevance
“…The efficacy and safety of L-menthol were evaluated in this open-label extension study that included subjects who had been excluded from a previous phase III, placebocontrolled study [14]. The results indicated that intragastric spraying of L-menthol was effective and safe in nearly all patients of the study cohort undergoing upper GI endoscopy.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The efficacy and safety of L-menthol were evaluated in this open-label extension study that included subjects who had been excluded from a previous phase III, placebocontrolled study [14]. The results indicated that intragastric spraying of L-menthol was effective and safe in nearly all patients of the study cohort undergoing upper GI endoscopy.…”
Section: Discussionmentioning
confidence: 99%
“…Patients were enrolled who required upper GI endoscopy, including those who had been excluded from an earlier placebo-controlled study of L-menthol [14] because they had reflux esophagitis (LA classification: B, C, D) or active gastric or duodenal ulcers, or had received sedation or transnasal endoscopy. The following exclusion criteria were applied to patients: (1) prior surgery involving upper GI tract; (2) severe gastric stenosis or deformation; (3) receiving treatment for cancer (chemotherapy or radiotherapy).…”
Section: Patientsmentioning
confidence: 99%
See 1 more Smart Citation
“…20 Recently, efficacy of topical administration of L-menthol (Minclea ® ; Nihon Pharmaceutical Co., Ltd, Tokyo, Japan) on reduction of gastric peristalsis during EGD is indicated. [21][22][23] This agent shows few side-effects. Need for antispasmodics during screening endoscopy needs to be clarified by well-designed clinical studies.…”
Section: Edicalmentioning
confidence: 99%
“…Эти препараты вводятся непосредственно перед исследованием и далее во время эндоскопи ческой процедуры. В последнее время опубликова ны сообщения об успешном применении раствора Lментола (0,8% раствор в объеме 20 мл) перораль но перед процедурой для подавления перистальти ческой активности [23][24][25], однако до настоящего времени не проводили хорошо спланированные клини ческие исследования, которые могли бы по казать влияние спазмолитиков на эффективность диагнос тики.…”
Section: спазмолитические препаратыunclassified